Is the blockbuster model dead? Turna Ray, who writes GT’s sister publication Pharmacogenomics Reporter, posited that this might be the case for big pharma, which hopes to one day sell therapies more aligned with personalized treatment.
Is the blockbuster model dead? Turna Ray, who writes GT’s sister publication Pharmacogenomics Reporter, posited that this might be the case for big pharma, which hopes to one day sell therapies more aligned with personalized treatment.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.